These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 34398430)

  • 1. Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2.
    Ma J; Chen Y; Wu W; Chen Z
    Virol Sin; 2021 Oct; 36(5):1104-1112. PubMed ID: 34398430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host and Viral Zinc-Finger Proteins in COVID-19.
    Esposito S; D'Abrosca G; Antolak A; Pedone PV; Isernia C; Malgieri G
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.
    Zheng YX; Wang L; Kong WS; Chen H; Wang XN; Meng Q; Zhang HN; Guo SJ; Jiang HW; Tao SC
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1134-1141. PubMed ID: 34159380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.
    Gupta M; Azumaya CM; Moritz M; Pourmal S; Diallo A; Merz GE; Jang G; Bouhaddou M; Fossati A; Brilot AF; Diwanji D; Hernandez E; Herrera N; Kratochvil HT; Lam VL; Li F; Li Y; Nguyen HC; Nowotny C; Owens TW; Peters JK; Rizo AN; Schulze-Gahmen U; Smith AM; Young ID; Yu Z; Asarnow D; Billesbølle C; Campbell MG; Chen J; Chen KH; Chio US; Dickinson MS; Doan L; Jin M; Kim K; Li J; Li YL; Linossi E; Liu Y; Lo M; Lopez J; Lopez KE; Mancino A; Moss FR; Paul MD; Pawar KI; Pelin A; Pospiech TH; Puchades C; Remesh SG; Safari M; Schaefer K; Sun M; Tabios MC; Thwin AC; Titus EW; Trenker R; Tse E; Tsui TKM; Wang F; Zhang K; Zhang Y; Zhao J; Zhou F; Zhou Y; Zuliani-Alvarez L; ; Agard DA; Cheng Y; Fraser JS; Jura N; Kortemme T; Manglik A; Southworth DR; Stroud RM; Swaney DL; Krogan NJ; Frost A; Rosenberg OS; Verba KA
    Res Sq; 2021 May; ():. PubMed ID: 34031651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
    Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
    J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.
    Gupta M; Azumaya CM; Moritz M; Pourmal S; Diallo A; Merz GE; Jang G; Bouhaddou M; Fossati A; Brilot AF; Diwanji D; Hernandez E; Herrera N; Kratochvil HT; Lam VL; Li F; Li Y; Nguyen HC; Nowotny C; Owens TW; Peters JK; Rizo AN; Schulze-Gahmen U; Smith AM; Young ID; Yu Z; Asarnow D; Billesbølle C; Campbell MG; Chen J; Chen KH; Chio US; Dickinson MS; Doan L; Jin M; Kim K; Li J; Li YL; Linossi E; Liu Y; Lo M; Lopez J; Lopez KE; Mancino A; Moss FR; Paul MD; Pawar KI; Pelin A; Pospiech TH; Puchades C; Remesh SG; Safari M; Schaefer K; Sun M; Tabios MC; Thwin AC; Titus EW; Trenker R; Tse E; Tsui TKM; Wang F; Zhang K; Zhang Y; Zhao J; Zhou F; Zhou Y; Zuliani-Alvarez L; ; Agard DA; Cheng Y; Fraser JS; Jura N; Kortemme T; Manglik A; Southworth DR; Stroud RM; Swaney DL; Krogan NJ; Frost A; Rosenberg OS; Verba KA
    bioRxiv; 2021 May; ():. PubMed ID: 34013269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonstructural protein 7 and 8 complexes of SARS-CoV-2.
    Zhang C; Li L; He J; Chen C; Su D
    Protein Sci; 2021 Apr; 30(4):873-881. PubMed ID: 33594727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
    Dai W; Zhang B; Jiang XM; Su H; Li J; Zhao Y; Xie X; Jin Z; Peng J; Liu F; Li C; Li Y; Bai F; Wang H; Cheng X; Cen X; Hu S; Yang X; Wang J; Liu X; Xiao G; Jiang H; Rao Z; Zhang LK; Xu Y; Yang H; Liu H
    Science; 2020 Jun; 368(6497):1331-1335. PubMed ID: 32321856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
    Fantini J; Di Scala C; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 May; 55(5):105960. PubMed ID: 32251731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of nonstructural protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    bioRxiv; 2020 Nov; ():. PubMed ID: 33173873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
    Baig MS; Alagumuthu M; Rajpoot S; Saqib U
    Drugs R D; 2020 Sep; 20(3):161-169. PubMed ID: 32592145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 NSP2 as a Potential Delivery Vehicle for Proteins.
    Zheng N; Liu S; Chen J; Xu Y; Cao W; Lin J; Lu G; Zhang G
    Mol Pharm; 2024 Mar; 21(3):1149-1159. PubMed ID: 38288708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.